Pregnancy and neonatal outcomes in women with immune mediated inflammatory diseases exposed to anti-tumor necrosis factor-α during pregnancy: A systemic review and meta-analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pregnancy and neonatal outcomes in women with immune mediated inflammatory diseases exposed to anti-tumor necrosis factor-α during pregnancy: A systemic review and meta-analysis
Authors
Keywords
TNFα, Pregnancy, IBD, Rheumatoid arthritis, Psoriasis
Journal
JOURNAL OF AUTOIMMUNITY
Volume 122, Issue -, Pages 102676
Publisher
Elsevier BV
Online
2021-06-11
DOI
10.1016/j.jaut.2021.102676
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris – Part 2: specific clinical and comorbid situations
- (2021) A. Nast et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Maternal and Neonatal Outcomes in Pregnant Women with Psoriasis and Psoriatic Arthritis: A Systematic Review and Meta-Analysis
- (2021) Wenhui Xie et al. RHEUMATOLOGY
- The positive effect of pregnancy in rheumatoid arthritis and the use of medications for the management of rheumatoid arthritis during pregnancy
- (2021) Uday Raj Sharma et al. INFLAMMOPHARMACOLOGY
- Anti‐TNF treatment during pregnancy and birth outcomes: A population‐based study from Denmark, Finland, and Sweden
- (2020) Gabriella Bröms et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- EULAR recommendations for a core data set for pregnancy registries in rheumatology
- (2020) Yvette Meissner et al. ANNALS OF THE RHEUMATIC DISEASES
- Pregnancy and Neonatal Outcomes After Fetal Exposure to Biologics and Thiopurines Among Women With Inflammatory Bowel Disease
- (2020) Uma Mahadevan et al. GASTROENTEROLOGY
- Modulatory Effects of Pregnancy on Inflammatory Bowel Disease
- (2019) Janine van der Giessen et al. Clinical and Translational Gastroenterology
- Use of biologics during pregnancy and risk of serious infections in the mother and baby: a Canadian population-based cohort study
- (2019) Nicole W Tsao et al. BMJ Open
- DOP29 Pregnancy outcomes in IBD patients treated with vedolizumab, anti-TNF, or conventional therapy
- (2019) A Moens et al. Journal of Crohns & Colitis
- Psoriasis Pathogenesis and Treatment
- (2019) Adriana Rendon et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Effect of biologic disease-modifying anti-rheumatic drugs for patients with rheumatoid arthritis who hope to become mothers
- (2019) Hiromi Shimada et al. CLINICAL RHEUMATOLOGY
- Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group
- (2019) Uma Mahadevan et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth Outcomes
- (2019) Mette Julsgaard et al. INFLAMMATORY BOWEL DISEASES
- British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults
- (2019) Christopher Andrew Lamb et al. GUT
- Safety of first year vaccination in children born to mothers with inflammatory bowel disease and exposed in utero to anti-TNFα agents: a French nationwide population-based cohort
- (2019) Maxime Luu et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Early Discontinuation of Infliximab in Pregnant Women With Inflammatory Bowel Disease
- (2019) Brindusa Truta et al. INFLAMMATORY BOWEL DISEASES
- Birth outcomes in women who have taken adalimumab in pregnancy: A prospective cohort study
- (2019) Christina D. Chambers et al. PLoS One
- Effect of Maternal Psoriasis on Pregnancy and Birth Outcomes: A Population-based Cohort Study from Denmark and Sweden
- (2018) G Bröms et al. ACTA DERMATO-VENEREOLOGICA
- Continuous Anti-TNFα Use Throughout Pregnancy: Possible Complications For the Mother But Not for the Fetus. A Retrospective Cohort on the French National Health Insurance Database (EVASION)
- (2018) Maxime Luu et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study
- (2018) M Chaparro et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Hepatitis B Vaccination Effective in Children Exposed to Anti-Tumour Necrosis Factor Alpha in Utero
- (2018) Alison de Lima et al. Journal of Crohns & Colitis
- Maternal and Fetal Outcomes in a Cohort of Patients Exposed to Tumor Necrosis Factor Inhibitors throughout Pregnancy
- (2018) Geneviève Genest et al. JOURNAL OF RHEUMATOLOGY
- Risk for adverse pregnancy outcome in axial spondyloarthritis and rheumatoid arthritis: disease activity matters
- (2018) Astrid Zbinden et al. RHEUMATOLOGY
- Patient-Reported Disease Activity and Adverse Pregnancy Outcomes in Systemic Lupus Erythematosus and Rheumatoid Arthritis
- (2018) Nathaniel Harris et al. ARTHRITIS CARE & RESEARCH
- Pregnant women with inflammatory bowel disease: the effects of biologicals on pregnancy, outcome of infants, and the developing immune system
- (2018) Jantien W. Wieringa et al. Expert Review of Gastroenterology & Hepatology
- Pregnancy Outcomes after Exposure to Certolizumab Pegol: Updated Results from a Pharmacovigilance Safety Database
- (2018) Megan E. B. Clowse et al. Arthritis & Rheumatology
- Serious infections in rheumatoid arthritis offspring exposed to tumour necrosis factor α inhibitors: cohort study
- (2018) Évelyne Vinet et al. Arthritis & Rheumatology
- Safety of Anti-TNF-Alpha Therapy During Pregnancy on Long-term Outcome of Exposed Children: A Controlled, Multicenter Observation
- (2018) Dana Duricova et al. INFLAMMATORY BOWEL DISEASES
- Clinical Practice Guideline for the Medical Management of Perianal Fistulizing Crohn’s Disease: The Toronto Consensus
- (2018) A Hillary Steinhart et al. INFLAMMATORY BOWEL DISEASES
- Pregnancy Outcomes of Patients Exposed to Adalimumab in Japan
- (2018) Yumi Kawai et al. DIGESTIVE DISEASES
- Anti–TNF-α Use During the Third Trimester of Pregnancy in Women with Moderate–severe Inflammatory Bowel Disease and the Risk of Preterm Birth and Low Birth Weight
- (2017) Heidi Kammerlander et al. INFLAMMATORY BOWEL DISEASES
- The Effect of Disease Activity on Birth Outcomes in a Nationwide Cohort of Women with Moderate to Severe Inflammatory Bowel Disease
- (2017) Heidi Kammerlander et al. INFLAMMATORY BOWEL DISEASES
- Pregnancy and foetal outcomes following anti-tumor necrosis factor alpha therapy: A prospective multicentre study
- (2017) Ariela Hoxha et al. JOINT BONE SPINE
- Outcome of pregnancy and neonatal complications with anti-tumor necrosis factor-α use in females with immune mediated diseases; a systematic review and meta-analysis
- (2017) Fukiko Komaki et al. JOURNAL OF AUTOIMMUNITY
- Pregnancy and infant outcomes including major congenital malformations among women with chronic inflammatory arthritis or psoriasis, with and without etanercept use
- (2017) Wendy J. Carman et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Fertility, Pregnancy, and Lactation in Rheumatoid Arthritis
- (2017) Pascal H.P. de Jong et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- Immunological Changes in Blood of Newborns Exposed to Anti-TNF-α during Pregnancy
- (2017) Ana Esteve-Solé et al. Frontiers in Immunology
- The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation
- (2016) Carina Götestam Skorpen et al. ANNALS OF THE RHEUMATIC DISEASES
- Adalimumab long-term safety: infections, vaccination response and pregnancy outcomes in patients with rheumatoid arthritis
- (2016) Gerd R Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- Low Risk of Birth Defects for Infants Whose Mothers Are Treated With Anti–Tumor Necrosis Factor Agents During Pregnancy
- (2016) Gabriella Bröms et al. Clinical Gastroenterology and Hepatology
- The Effect of Maternal Peripartum Anti-TNFα Use on Infant Immune Response
- (2016) Sarah Sheibani et al. DIGESTIVE DISEASES AND SCIENCES
- The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy
- (2016) Geoffrey C. Nguyen et al. GASTROENTEROLOGY
- Safe and effective: anti-tumour necrosis factor therapy use in pregnant patients with Crohn disease and ulcerative colitis
- (2016) C. J. Kiely et al. INTERNAL MEDICINE JOURNAL
- Pregnancy outcome after TNF-α inhibitor therapy during the first trimester: a prospective multicentre cohort study
- (2015) Corinna Weber-Schoendorfer et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Tailored anti-TNF therapy during pregnancy in patients with IBD: maternal and fetal safety
- (2015) A de Lima et al. GUT
- Disease Severity and Pregnancy Outcomes in Women with Rheumatoid Arthritis: Results from the Organization of Teratology Information Specialists Autoimmune Diseases in Pregnancy Project
- (2015) B. Bharti et al. JOURNAL OF RHEUMATOLOGY
- 865 PIANO: A 1000 Patient Prospective Registry of Pregnancy Outcomes in Women With IBD Exposed to Immunomodulators and Biologic Therapy
- (2015) Uma Mahadevan et al. GASTROENTEROLOGY
- Factors associated with pregnancy outcome in anti-TNF treated women with inflammatory bowel disease
- (2014) M. Seirafi et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Impact of Anti–Tumor Necrosis Factor Alpha Antibodies Administered to Pregnant Women With Inflammatory Bowel Disease on Long-term Outcome of Exposed Children
- (2014) Martin Bortlik et al. INFLAMMATORY BOWEL DISEASES
- Assessing Bias in Studies of Prognostic Factors
- (2013) Jill A. Hayden et al. ANNALS OF INTERNAL MEDICINE
- Pregnancy outcome following gestational exposure to TNF-alpha-inhibitors: A prospective, comparative, observational study
- (2013) Orna Diav-Citrin et al. REPRODUCTIVE TOXICOLOGY
- Pregnancy and newborn outcome of mothers with inflammatory bowel diseases exposed to anti-TNF-α therapy during pregnancy: three-center study
- (2013) Martin Bortlik et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Brief Report: Risk of Adverse Fetal Outcomes Associated With Immunosuppressive Medications for Chronic Immune-Mediated Diseases in Pregnancy
- (2013) William O. Cooper et al. Arthritis & Rheumatology
- Effects of Discontinuing Anti–Tumor Necrosis Factor Therapy During Pregnancy on the Course of Inflammatory Bowel Disease and Neonatal Exposure
- (2012) Zuzana Zelinkova et al. Clinical Gastroenterology and Hepatology
- Is safety infliximab during pregnancy in patients with inflammatory bowel disease?
- (2012) Federico Argüelles-Arias et al. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
- Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register
- (2011) S. M. M. Verstappen et al. ANNALS OF THE RHEUMATIC DISEASES
- Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy
- (2011) Fabian Schnitzler et al. INFLAMMATORY BOWEL DISEASES
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Exposition to anti-TNF drugs during pregnancy: Outcome of 15 cases and review of the literature
- (2008) Jean-Marie Berthelot et al. JOINT BONE SPINE
- Human Tumour Necrosis Factor: Physiological and Pathological Roles in Placenta and Endometrium
- (2008) S. Haider et al. PLACENTA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More